IPP Bureau
Cadila launches Cadilose for constipation and hepatic encephalopathy
By IPP Bureau - March 26, 2025
Glenmark launches nutrition program to fight malnutrition in Philippines
By IPP Bureau - March 26, 2025
This program, titled "Food Supplementation and Capacity Building Support for Improved Nutrition in Malinao, Aklan," aligns with the country’s national health
Alembic Pharma and Amlan International partner to advance poultry health in India
By IPP Bureau - March 26, 2025
Alembic Pharmaceuticals Ltd. and Amlan International sign exclusive strategic commercial agreement to make poultry health innovations accessible to Indian farmers and integrators
Merck inks $200 million deal for Hengrui's midstage heart disease drug
By IPP Bureau - March 26, 2025
Hengrui Pharma has granted Merck exclusive rights to develop, manufacture and commercialize HRS-5346 worldwide, excluding Greater China region
Wipro announces AI Agent Solutions across healthcare industry
By IPP Bureau - March 25, 2025
Wipro’s agents for Agentforce will elevate efficiency and customer satisfaction at healthcare companies
Our TB elimination strategy is based on ‘whole of the society’ and ‘whole of the government’ approach: JP Nadda
By IPP Bureau - March 25, 2025
Nadda noted that TB treatment coverage in India has increased from 59% to 85%
Lilly launches Mounjaro in India for treatment of obesity and type 2 diabetes
By IPP Bureau - March 24, 2025
Adults taking Mounjaro with diet and exercise in a controlled clinical trial lost on average 21.8 kg at the highest dose (15mg) and 15.4 kg at the lowest dose (5mg)
Briefs: Alembic Pharmaceuticals and Shelter Pharma
By IPP Bureau - March 24, 2025
Alembic Pharmaceuticals successfully completes USFDA inspection for API-III facility
Marksans Pharma’s manufacturing facility at Verna, Goa approved by Australian TG
By IPP Bureau - March 24, 2025
The products will be manufactured in Goa India and marketed & distributed in Australian markets
AstraZeneca to invest $2.5 billion in new global strategic R&D centre in China
By IPP Bureau - March 24, 2025
Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai
J&J to break ground on new biologics facility in North Carolina
By IPP Bureau - March 24, 2025
New facility will support plans to advance J&J’s portfolio and pipeline of transformational medicines for cancer, immune-mediated and neurological diseases
Neuland appoints Parag Deshmukh as SVP – Head of Manufacturing
By IPP Bureau - March 24, 2025
Prior to joining Neuland, Deshmukh held several key positions at Cipla
Nanomi receives CMO Award for Life Science Leadership in drug delivery
By IPP Bureau - March 22, 2025
Nanomi's pioneering approach in drug delivery has set new benchmarks in the industry, and this award serves as a motivation to continue its mission to revolutionize healthcare
SMS Pharmaceuticals completes USFDA inspection at Hyderabad facility
By IPP Bureau - March 22, 2025
The inspection, conducted from March 17 to March 21, 2025, concluded with one observation in Form 483
Lupin bags EcoVadis Silver Medal for sustainability excellence
By IPP Bureau - March 21, 2025
Over the last two years, Lupin has showcased exceptional improvement in its EcoVadis scoring
